Revvity Gene Delivery GMBH
Gräfelfing, BY Revvity Gene Delivery GMBH
- UEI
- MSN6VLEJCHC5
- CAGE
- DQ0D0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Am Haag 6, 82166 Gräfelfing, Germany
- Website
- sirion-biotech.com
- Founded
- 2007
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Lentiboost formulated, gmpgrade | NIH Clinical Center | $21,000 | |
| Lentiboost formulated, GMP-grade | NIH Clinical Center | $21,000 | |
| Lentiboost formulated, GMP-grade | NIH Clinical Center | $10,970 | |
| Lentiboost formulated, GMP-grade 1 x 1 ML | NIH Clinical Center | $12,887 | |
| Lentiboost formulated, GMP-grade; reagent for patient treatment. | NIH Clinical Center | $10,250 |
About Revvity Gene Delivery GMBH
Sirion Biotech GMBH is a foreign-owned, for-profit organization that specializes in providing viral vector technologies and products to support gene therapy research and patient treatments. The company has been registered to receive awards from the U.S. federal government since January 7, 2019, with its current registration in SAM.gov set to expire on February 15, 2025. Sirion Biotech GMBH primarily supplies LENTIBOOST formulated, GMP-grade viral vector products to the federal government, specifically to the Department of Health and Human Services National Institutes of Health Clinical Center. These high-quality, specialized reagents are crucial for advancing gene therapy research and supporting patient treatments in clinical settings.
The company has consistently secured prime federal contract awards from the NIH Clinical Center, with no subcontractors or set-aside designations mentioned in the available data. These awards have been in the form of firm-fixed price purchase orders, ranging in value from approximately $10,000 to $21,000. The goods provided by Sirion Biotech GMBH include LENTIBOOST formulated, GMP-grade lentiviral products and other viral vector reagents. These products are typically delivered from the company's facilities in Germany to meet specified completion dates, which have ranged from about one month to six months after the award date. The consistency in contract awards from 2021 to 2024 suggests an ongoing relationship between Sirion Biotech GMBH and the NIH Clinical Center, highlighting the company's important role in supporting the NIH's intramural research program and its efforts to advance treatments for complex medical conditions through gene therapy.
Quick answers
What is Revvity Gene Delivery GMBH's UEI?
Revvity Gene Delivery GMBH's Unique Entity ID (UEI) in SAM.gov is MSN6VLEJCHC5.
What is Revvity Gene Delivery GMBH's CAGE code?
Revvity Gene Delivery GMBH's CAGE code is DQ0D0.
What is Revvity Gene Delivery GMBH's primary NAICS code?
Revvity Gene Delivery GMBH's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Revvity Gene Delivery GMBH located?
Revvity Gene Delivery GMBH's physical address in SAM.gov is Am Haag 6, 82166 Gräfelfing, Germany.
Is Revvity Gene Delivery GMBH registered in SAM.gov?
Yes. Revvity Gene Delivery GMBH's SAM.gov registration is active through June 4, 2027.
What is Revvity Gene Delivery GMBH's most recent federal award?
Revvity Gene Delivery GMBH's most recent federal contract award is Lentiboost formulated, gmpgrade (75N90024P00380), from NIH Clinical Center, on May 7, 2024.
On GovTribe
See Revvity Gene Delivery GMBH's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors